AvalehtSTAR • NSE
add
Strides Pharma Science Ltd
Viimane sulgemishind
1643,30 ₹
Tänane vahemik
1593,55 ₹ - 1654,95 ₹
Aasta vahemik
467,00 ₹ - 1675,00 ₹
Turuväärtus
149,79 mld INR
Keskmine maht
349,47 tuh
P/E suhe
3 343,12
Dividendimäär
0,15%
Põhibörs
NSE
Börsiuudised
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
(INR) | juuni 2024info | Y/Y muutus |
---|---|---|
Käive | 10,88 mld | 16,94% |
Põhitegevusega seonduv kulu | 4,99 mld | 13,84% |
Puhastulu | 702,02 mln | 1 086,95% |
Puhaskasumimarginaal | 6,46 | 950,00% |
Puhaskasum aktsia kohta | — | — |
EBITDA | 2,24 mld | 33,22% |
Tõhus maksumäär | 19,80% | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
(INR) | juuni 2024info | Y/Y muutus |
---|---|---|
Sularaha ja lühiajalised investeeringud | 2,97 mld | −19,05% |
Kogu vara | — | — |
Kõik kohustused | — | — |
Kogu omakapital | 20,72 mld | — |
Emiteeritud aktsiate arv | 91,89 mln | — |
Hinna ja väärtuse suhe P/B | 7,10 | — |
Varade tasuvus | — | — |
Kapitali tasuvus | 9,17% | — |
Rahavoog
Raha ja raha ekvivalentide muutus
(INR) | juuni 2024info | Y/Y muutus |
---|---|---|
Puhastulu | 702,02 mln | 1 086,95% |
Põhitegevuse rahakäive | — | — |
Investeeringute raha | — | — |
Finantseerimise raha | — | — |
Raha ja raha ekvivalentide muutus | — | — |
Tasuta rahavoog | — | — |
Teave
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore in southern India. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. Its softgel manufacturing capability consists of an annual capacity of 50,000 machine hours or about three billion softgel capsules. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. In the United States and Canadian markets, the company partners with generic companies to supply retail and hospital generics in injectable products and softgels. In European markets, it has long-term relationships for the development of projects and supply agreements with the European companies. In Australia and New Zealand, the company is engaged in manufacturing and supply of soft gels and value-added manufacturing. The company has development and supply agreements with South African companies. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India. Wikipedia
Asutatud
1990
Peakontor
Veebisait
Töötajate arv
3 065